Alicia Lenzen

857 total citations
25 papers, 437 citations indexed

About

Alicia Lenzen is a scholar working on Genetics, Molecular Biology and Neurology. According to data from OpenAlex, Alicia Lenzen has authored 25 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 6 papers in Molecular Biology and 6 papers in Neurology. Recurrent topics in Alicia Lenzen's work include Glioma Diagnosis and Treatment (14 papers), Neuroblastoma Research and Treatments (4 papers) and Tryptophan and brain disorders (4 papers). Alicia Lenzen is often cited by papers focused on Glioma Diagnosis and Treatment (14 papers), Neuroblastoma Research and Treatments (4 papers) and Tryptophan and brain disorders (4 papers). Alicia Lenzen collaborates with scholars based in United States, Canada and Germany. Alicia Lenzen's co-authors include Lijie Zhai, Kristen L. Lauing, Erik Ladomersky, Derek A. Wainwright, Brenda Nguyen, Ricky Patel, Meijing Wu, David C. Binder, Sebastian Otto‐Meyer and Rimas V. Lukas and has published in prestigious journals such as Cancers, Neuro-Oncology and Cellular and Molecular Immunology.

In The Last Decade

Alicia Lenzen

22 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alicia Lenzen United States 7 183 137 133 85 84 25 437
Sidharth Mahapatra United States 14 277 1.5× 98 0.7× 148 1.1× 18 0.2× 66 0.8× 32 513
Rachel Popow United States 5 97 0.5× 293 2.1× 261 2.0× 72 0.8× 23 0.3× 6 611
Abdullah Alsuliman United States 9 105 0.6× 236 1.7× 225 1.7× 21 0.2× 75 0.9× 15 588
Chuanhong Zhong China 12 202 1.1× 57 0.4× 94 0.7× 20 0.2× 58 0.7× 21 372
Yuko Miyasato Japan 9 139 0.8× 207 1.5× 164 1.2× 7 0.1× 64 0.8× 11 414
Paul DePietro United States 11 123 0.7× 186 1.4× 250 1.9× 46 0.5× 10 0.1× 41 451
Sarabjot Pabla United States 15 199 1.1× 251 1.8× 422 3.2× 48 0.6× 18 0.2× 77 720
Jennifer Kleponis United States 6 204 1.1× 129 0.9× 220 1.7× 16 0.2× 9 0.1× 7 382
Soheil Zorofchian United States 8 114 0.6× 29 0.2× 52 0.4× 16 0.2× 137 1.6× 10 336
Jeremy S. Frieling United States 10 100 0.5× 101 0.7× 184 1.4× 9 0.1× 21 0.3× 21 327

Countries citing papers authored by Alicia Lenzen

Since Specialization
Citations

This map shows the geographic impact of Alicia Lenzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alicia Lenzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alicia Lenzen more than expected).

Fields of papers citing papers by Alicia Lenzen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alicia Lenzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alicia Lenzen. The network helps show where Alicia Lenzen may publish in the future.

Co-authorship network of co-authors of Alicia Lenzen

This figure shows the co-authorship network connecting the top 25 collaborators of Alicia Lenzen. A scholar is included among the top collaborators of Alicia Lenzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alicia Lenzen. Alicia Lenzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fangusaro, Jason, Arzu Onar‐Thomas, Tina Young Poussaint, et al.. (2025). A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4. Neuro-Oncology. 27(9). 2415–2428. 2 indexed citations
2.
Boland, Lauren, Melissa J. Williams, Alicia Lenzen, et al.. (2024). DEI-01. CLINICAL AND SOCIOECONOMIC FACTORS ASSOCIATED WITH PARTICIPATION IN POST-MORTEM TISSUE DONATION IN PEDIATRIC BRAIN TUMORS: A RETROSPECTIVE CHART REVIEW. Neuro-Oncology. 26(Supplement_4). 0–0.
3.
4.
5.
6.
Monje, Michelle, Tabitha Cooney, John Glod, et al.. (2023). Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047). Neuro-Oncology. 25(12). 2262–2272. 31 indexed citations
7.
Lai, Jin‐Shei, Sally E. Jensen, John Devin Peipert, et al.. (2023). Using IT to Improve Outcomes for Children Living With Cancer (SyMon-SAYS): Protocol for a Single-Institution Waitlist Randomized Controlled Trial. JMIR Research Protocols. 12. e50993–e50993. 2 indexed citations
8.
Najem, Hinda, Shashwat Tripathi, Craig Horbinski, et al.. (2023). Immunobiology and Cytokine Modulation of the Pediatric Brain Tumor Microenvironment: A Scoping Review. Cancers. 15(14). 3655–3655. 4 indexed citations
9.
Cacciotti, Chantel, Christine Chordas, Alicia Lenzen, et al.. (2022). Cardiac dysfunction in medulloblastoma survivors treated with photon irradiation. Neuro-Oncology Practice. 9(4). 338–343. 5 indexed citations
10.
Lenzen, Alicia, et al.. (2021). Refractory Epilepsy as a Late Effect of Chemoradiation in Childhood Cancer: A Case Series. Pediatric Neurology. 127. 56–59. 1 indexed citations
11.
Wadhwani, Nitin R., et al.. (2021). Pediatric spinal intramedullary anaplastic myxopapillary ependymoma: a case report. Child s Nervous System. 38(1). 223–227. 1 indexed citations
12.
Smith, Stephen B., Beng Fuh, Arun Rangaswami, et al.. (2021). Therapy‐related myeloid neoplasms resembling juvenile myelomonocytic leukemia: a case series and review of the literature. Pediatric Blood & Cancer. 69(5). e29499–e29499. 1 indexed citations
13.
Fangusaro, Jason, Arzu Onar‐Thomas, Shengjie Wu, et al.. (2020). LGG-04. A PHASE II RE-TREATMENT STUDY OF SELUMETINIB FOR RECURRENT OR PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (pLGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY. Neuro-Oncology. 22(Supplement_3). iii367–iii367. 2 indexed citations
14.
Lenzen, Alicia, Kristen L. Lauing, Lijie Zhai, et al.. (2019). IMMU-01. NOVEL RNA-TARGETING STRATEGY FOR TREATING T CELL-DRIVEN IMMUNOSUPPRESSION IN HUMAN DIFFUSE INTRINSIC PONTINE GLIOMA. Neuro-Oncology. 21(Supplement_2). ii92–ii93. 2 indexed citations
15.
Ladomersky, Erik, Sebastian Otto‐Meyer, Lijie Zhai, et al.. (2018). IMMU-46. GLIOBLASTOMA PATIENT DIAGNOSES AND IMMUNOSUPPRESSION ARE MAXIMAL DURING OLD AGE: A RANDOM COINCIDENCE, OR CAUSE AND EFFECT?. Neuro-Oncology. 20(suppl_6). vi131–vi131. 1 indexed citations
16.
Zhai, Lijie, Erik Ladomersky, Alicia Lenzen, et al.. (2018). IDO1 in cancer: a Gemini of immune checkpoints. Cellular and Molecular Immunology. 15(5). 447–457. 311 indexed citations
17.
Lauing, Kristen L., Rishi Lulla, Alicia Lenzen, et al.. (2017). IMMU-35. TARGETING IDO1 IN HUMAN PEDIATRIC BRAIN CANCER. Neuro-Oncology. 19(suppl_6). vi120–vi120. 1 indexed citations
18.
Lenzen, Alicia, Lijie Zhai, Kristen L. Lauing, & Galina Gritsina. (2016). The Kynurenine/Tryptophan Ratio and Glioblastoma Patients Treated with Hsppc-96 Vaccine. PubMed. 2(3). 8 indexed citations
19.
Ladomersky, Erik, Matthew Genet, Lijie Zhai, et al.. (2016). Improving vaccine efficacy against malignant glioma. OncoImmunology. 5(8). e1196311–e1196311. 16 indexed citations
20.
Walz, Amy L., et al.. (2014). Use of allogeneic stem cell transplantation for moderate–severe Glanzmann thrombasthenia. Platelets. 26(7). 702–704. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sidharth Mahapatra Breakdown of academic impact, for papers by Rachel Popow Breakdown of academic impact, for papers by Abdullah Alsuliman Breakdown of academic impact, for papers by Chuanhong Zhong Breakdown of academic impact, for papers by Yuko Miyasato Breakdown of academic impact, for papers by Paul DePietro Breakdown of academic impact, for papers by Sarabjot Pabla Breakdown of academic impact, for papers by Jennifer Kleponis Breakdown of academic impact, for papers by Soheil Zorofchian Breakdown of academic impact, for papers by Jeremy S. Frieling
Rankless by CCL
2026